TP53 and cancer: Another study in accordance with Hampson et al. (2006) showed that HIV protease inhibitors caused evident depletion of E6 and E7, which correlated with increased p53 levels associated with anticancer properties in HPV-positive cancer cells (Park et al., 2021).